digital currency in pakistan, Overview

Jiangxi-Guangdong Expressway: Contemporary Amperex Technology Co., Limited Jiangxi Zero-carbon Ecological Development Department visited the company to explore new technologies for the construction of "Meilu Expressway". Recently, Qiao Pengfei, general manager of Jiangxi Zero-carbon Ecological Development Department of Contemporary Amperex Technology Co., Limited, and his party visited Jiangxi-Guangdong Expressway to discuss the construction of "Meilu Expressway". Han Feng, Party Secretary and Chairman of Jiangxi-Guangdong Expressway, and Liang Zhiai, member of the Party Committee, attended the discussion, and responsible comrades from relevant departments of both sides attended. Qiao Pengfei introduced Contemporary Amperex Technology Co., Limited's cutting-edge technologies and innovative solutions in the field of low-carbon and zero-carbon, especially its achievements and practical experience in new energy. He said that Contemporary Amperex Technology Co., Limited is committed to providing customized zero-carbon solutions for different industries, and the expressway scene contains huge potential for energy conservation and emission reduction. He hoped that both sides could jointly explore new technologies and new ideas for the construction of "Meilong Expressway" and contribute to the green and low-carbon development of the transportation industry.The tourism and hotel sector oscillated to raise the daily limit of Qujiang Wenlv, while the tourism and hotel sector oscillated to raise the daily limit of Qujiang Wenlv, followed by Xi 'an Catering, Xi 'an Tourism, Dalian Shengya, Lingnan Holdings and Zhangjiajie.Yunnan Baiyao and others set up the equity fund of TCM Big Health Innovation. The enterprise search APP shows that recently, Yunnan TCM Big Health Innovation Equity Investment Fund Partnership (Limited Partnership) was established with a capital contribution of 7 billion yuan, and its business scope includes: engaging in equity investment, investment management, asset management and other activities with private equity funds. Enterprise investigation shows that the enterprise is jointly held by Yunnan Baiyao and BOC International Investment Co., Ltd., a wholly-owned subsidiary of BOC Securities.

FTSE China A50 index futures opened 0.13% higher, and closed down 0.01% in the last session.The Australian dollar's yield on Australian bonds rose. The Australian employment data was better than expected, and the Australian dollar's gains expanded. The previously released data showed that the unemployment rate in Australia unexpectedly fell last month, which cooled the speculation surrounding the Australian central bank's interest rate cut. AUD/USD rose 0.7% to 0.6412; Report 0.6378 before data release. The yield of 3-year Australian government bonds rose from 3.75% before the data was released to 3.79%.Nanshan Holdings: The obvious effect of the property market policy has yet to be implemented by various measures. In view of the sales situation of the company's real estate development business since September 24, Nanshan Holdings (002314) said in a conference call with institutional investors on December 11 that since September 24, the central government has actively released the signal to stabilize the property market, and some real estate markets have stopped falling, but the foundation for the national property market to stop falling and stabilize is still not solid, and the obvious effect of the policy still needs to be implemented by various measures. The company will continue to pay close attention to policy trends, actively respond to market changes, promote the company's project sales, and improve the company's operating performance.

Baolingbao and Fengli Jingqiu reached a strategic cooperation. On December 11th, Baolingbao Biological Co., Ltd. (referred to as "Baolingbao") and Beijing Fengli Jingqiu Pharmaceutical Co., Ltd. (referred to as "Fengli Jingqiu") formally signed an agreement to start the strategic cooperation of lactulose bulk drug products. The two sides will carry out global technology and market expansion in the field of pharmaceutical raw materials.Baolingbao and Fengli Jingqiu reached a strategic cooperation. On December 11th, Baolingbao Biological Co., Ltd. (referred to as "Baolingbao") and Beijing Fengli Jingqiu Pharmaceutical Co., Ltd. (referred to as "Fengli Jingqiu") formally signed an agreement to start the strategic cooperation of lactulose bulk drug products. The two sides will carry out global technology and market expansion in the field of pharmaceutical raw materials.Retail stocks rose again, and Maoye Commercial, Zhongbai Group, Youa Shares, Liangpin Shop, Dashang Shares, Dongbai Group and other collective daily limit.